About Anagenex
Anagenex is a company based in San Francisco (United States) founded in 2019 by Nicolas Tilmans. Anagenex has raised $30 million across 2 funding rounds from investors including Khosla Ventures, Catalio Capital Management and Lux Capital. The company has 23 employees as of December 31, 2022. Anagenex offers products and services including AI Drug Discovery Platform. Anagenex operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.
- Headquarter San Francisco, United States
- Employees 23 as on 31 Dec, 2022
- Founders Nicolas Tilmans
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Anagenex, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$30 M (USD)
in 2 rounds
-
Latest Funding Round
$30 M (USD), Series A
Jun 08, 2022
-
Investors
Khosla Ventures
& 5 more
-
Employee Count
23
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Anagenex
Anagenex offers a comprehensive portfolio of products and services, including AI Drug Discovery Platform.
Platform tests billions of molecules for disease treatments and AI refinement.
People of Anagenex
Unlock access to complete
Unlock access to complete
Leadership Team
3 people
Independent Team
1 people
Research Team
1 people
Principal Team
1 people
Unlock access to complete
Funding Insights of Anagenex
Anagenex has successfully raised a total of $30M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $30 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Anagenex
Anagenex has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Khosla Ventures, Catalio Capital Management and Lux Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided to biomedical technology startups.
|
Locked | Locked | Locked | |
|
Seed and early-stage technology companies are funded by Lux Capital.
|
Locked | Locked | Locked | |
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked |
Investor details for Anagenex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Anagenex
Investment portfolio details for Anagenex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Anagenex
Detailed financials for Anagenex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Anagenex Comparisons
Peer comparison for Anagenex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Anagenex
Anagenex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An agentic AI platform is developed for biomedical research insights.
|
|
| Locked | Locked | Locked |
AI-powered drug discovery platform for various diseases
|
|
| Locked | Locked | Locked |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| Locked | Locked | Locked |
Antibody therapies are developed through machine learning and synthetic biology.
|
|
| Locked | Locked | Locked |
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
|
| Locked | Locked | Locked |
AI platform used for extracting antibody data from scientific papers.
|
Detailed competitors of Anagenex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Anagenex
Complete news archive for Anagenex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anagenex
Anagenex was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Anagenex is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Nicolas Tilmans is the current CEO of Anagenex. They have also founded this company.
Anagenex is a funded company, having raised a total of $30M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Anagenex is 23.
Anagenex was founded in 2019 and is headquartered in San Francisco, United States. Drug discovery services are provided through manufacturing processes in the biotechnology sector. Operations center on supporting pharmaceutical research and development needs. The company is led by Nicolas Tilmans, who serves as Founder and CEO. Focus remains on efficient service delivery for industry clients in the region.
Anagenex's top competitors include Owkin, Formation Bio and XtalPi.
Anagenex offers AI Drug Discovery Platform.
Anagenex has 6 investors. Key investors include Khosla Ventures, Catalio Capital Management, Lux Capital, Obvious Ventures, and Air Street Capital.